- Home
- EQIX vs BMY Comparison
EQIX vs BMY Comparison
Compare EQIX & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQIX
- BMY
- Stock Information
- Founded
- EQIX 1998
- BMY 1887
- Country
- EQIX United States
- BMY United States
- Employees
- EQIX N/A
- BMY N/A
- Industry
- EQIX Real Estate Investment Trusts
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- EQIX Real Estate
- BMY Health Care
- Exchange
- EQIX Nasdaq
- BMY Nasdaq
- Market Cap
- EQIX 87.1B
- BMY 97.6B
- IPO Year
- EQIX 2000
- BMY N/A
- Fundamental
- Price
- EQIX $756.70
- BMY $46.86
- Analyst Decision
- EQIX Strong Buy
- BMY Hold
- Analyst Count
- EQIX 22
- BMY 16
- Target Price
- EQIX $954.65
- BMY $58.00
- AVG Volume (30 Days)
- EQIX 930.8K
- BMY 14.3M
- Earning Date
- EQIX 07-30-2025
- BMY 07-31-2025
- Dividend Yield
- EQIX 2.48%
- BMY 5.29%
- EPS Growth
- EQIX N/A
- BMY N/A
- EPS
- EQIX 9.59
- BMY 2.67
- Revenue
- EQIX $8,814,000,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- EQIX $7.69
- BMY N/A
- Revenue Next Year
- EQIX $7.98
- BMY N/A
- P/E Ratio
- EQIX $78.92
- BMY $17.55
- Revenue Growth
- EQIX 5.67
- BMY 4.62
- 52 Week Low
- EQIX $701.41
- BMY $39.93
- 52 Week High
- EQIX $994.03
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- EQIX 29.38
- BMY 45.47
- Support Level
- EQIX $710.52
- BMY $46.33
- Resistance Level
- EQIX $777.77
- BMY $48.61
- Average True Range (ATR)
- EQIX 29.16
- BMY 0.92
- MACD
- EQIX -7.11
- BMY 0.10
- Stochastic Oscillator
- EQIX 23.08
- BMY 28.07
About EQIX Equinix Inc. REIT
Equinix operates 260 data centers in 71 markets worldwide. It generates 44% of total revenue in the Americas, 35% in Europe, the Middle East, and Africa, and 21% in Asia-Pacific. The firm has more than 10,000 customers, including 2,100 network providers, that are dispersed over five verticals: cloud and IT services, content providers, network and mobile services, financial services, and enterprise. About 70% of Equinix's revenue comes from renting space to tenants and related services, and more than 15% comes from interconnection. Equinix operates as a real estate investment trust.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.